Gipson, Gregory R.
Nolan, Kristof
Kattamuri, Chandramohan
Kenny, Alan P.
Agricola, Zachary
Edwards, Nicole A.
Zinski, Joseph
Czepnik, Magdalena
Mullins, Mary C.
Zorn, Aaron M.
Thompson, Thomas B.
Funding for this research was provided by:
National Institute of General Medical Sciences (R35 GM134923-03, R35 GM131908)
Article History
Received: 6 September 2022
Accepted: 19 January 2023
First Online: 1 February 2023
Declarations
:
: <i>Xenopus</i> experiments were performed in compliance with ethical regulations outlined by the NIH and institutional guidelines under Cincinnati Children's Hospital Medical Center Institutional Animal Care and Use Committee (IACUC) approved protocol IACUC2022-0026, approved 7/22/2022.Zebrafish, Danio rerio, experiments were performed in compliance with ethical regulations outlined by the NIH and institutional guidelines under the University of Pennsylvania Institutional Animal Care and Use Committee (IACUC) protocol 804214, approved 03/04/2022.
: Not applicable.
: T.B.T is a consultant for Alnylam Pharmaceuticals and Keros Therapeutics. The remaining authors have nothing to declare.